Omar Serang

Sevin Rosen Bayless Management Co (Sevin Rosen Bayless) is a venture capital firm founded in 1981. The firm is headquartered in Dallas, Texas.

Cybergold, Inc. provides direct marketing & advertising solutions for on-line advertisers and marketers. It provides internet-based direct marketing and advertising services with programs that reward consumers with cash when they perform actions desired by advertising and marketing clients. The services provided by the company primarily include production and development of marketing programs, delivery of targeted e-mail to its members, design of customer web sites and third party engineering functions. Cybergold was founded by Nat Goldhaber in 1995 and is located in Oakland, CA.

Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA.

Nodality, Inc. develops bioinformatics tools to enhance drug development process. Its technology profiles signaling networks in single cells by multiparametric phospho-flow cytometry. The company was founded by Michael C. Needels, Omar D. Perez, Garry P. Nolan and Rodney Weldon Turner in 2003 and is headquartered in San Francisco, CA.

Medtronic Monitoring, Inc. treats cardiac arrhythmias. The company was founded in 2005 and is headquartered in San Jose, CA.

EcoFactor, Inc. provides personalized residential energy management solutions. Its services include proactive energy efficiency, optimized demand response and HVAC performance monitoring. The firm powers residential energy saving services through its integrated SaaS platform. The company was founded by Scott Hublou and John Steinberg in 2006 and is headquartered in Redwood, CA.

eHealthInsurance Serivces, Inc. provides online health insurance plan services. It provides buying and using health insurance information through toll free number, online chat, email, fax, customer care team. The firm’s customers include individuals, families and small businesses. The company was founded in 1997 and is headquartered in Mountain View, CA.

Axion Pharmaceuticals, Inc. provides cancer therapy products. It is headquartered in South San Francisco, CA.

Claremont Creek Ventures (Claremont Creek) is a venture capital firm founded in 2005 by Nat Goldhaber, Randy Hawks and John Steuart. The firm is headquartered in Oakland, California.

Bayer CropScience, Inc. manufactures crop protection products. Its products include agricultural insecticides, fungicides, herbicides, and seed systems for the crop protection, biotechnology, and seed markets under the brand names InVigor, Admire, and Decis. The company offers integrated product portfolio of seed treatment technologies and plant biotechnology. Bayer CropScience is headquartered in Calgary, Canada.

MDV Management Co. LLC (MDV Management) is a venture capital firm founded in 1983. The firm is headquartered in San Mateo, CA.

CureSearch for Children's Cancer dedicates private funds for childhood cancer research for the Children's Oncology Group. Its Children's Oncology Group has a network of more than 5,000 physicians, nurses, and scientists whose collaboration, research, and care have turned childhood cancer from a virtually incurable disease to one with an overall 78% cure rate. The company was founded by Dr. G. Denman Hammond and is headquartered in Bethesda, MD.

Aaxion, Inc. manufactures and supplies fluid connectors. Its products include Parker hose, brass, industrial tube fittings, high pressure polyflex, parflex, quick couplings, and hydraulic valves. The company was founded in 1979 and is headquartered in Tyler, TX

The Personalized Medicine Coalition promotes the understanding and adoption of personalized medicine concepts, services, and products. The private company is based in Washington and was founded by Patrick F. Terry.

Innovatus Capital Partners LLC (Innovatus Capital) is a private equity firm founded in 2015 by Andrew Richard Dym and David Marc Schiff. The firm is headquartered in New York.

LifeMine Therapeutics, Inc. develops drugs from fungi which aims to cure untreatable and significant chronic diseases. The company was founded by Gregory L. Verdine, WeiQing Zhou, Richard D. Klausner and Hingge Hsu and is headquartered in Cambridge, MA.

TPG Alternative & Renewable Technologies (TPG ART) is a private equity arm of TPG Capital Advisors LLC founded in 1992 by David Bonderman and Jim Coulter. The firm is headquartered in Fort Worth, Texas.

Yor Labs, Inc. offers an ultraportable-handheld device for diagnostic care. The company is headquartered in Portland, OR.

Qiming US Ventures Management LLC (Qiming Venture Partners) is a Venture Capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts.

Innovatus Life Sciences Acquisition Corp. is a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on January 8, 2021 and is headquartered in New York, NY.

Part of NEUCA SA, OncoBay Clinical, Inc. is a boutique clinical research organization that specializes in immuno-oncology/cellular therapy. The company is based in Raleigh, NC and was founded by Krystyna Kowalczyk, who has been the CEO since incorporation. The company has extensive experience in oncology drug development and offers full-service custom-curated CRO solutions for pharmaceutical and biotech companies looking to advance their immuno-oncology product or device. OncoBay Clinical collaborates with the Leukemia & Lymphoma Society on its groundbreaking Beat AML® Master Clinical Trial, the first collaborative precision medicine clinical trial for a blood cancer. OncoBay Clinical was acquired by NEUCA SA on January 04, 2023 for $51.50 million.